Harris JP, Fujimoto DK, Nagasaka M, Ku E, et al. Controversies in Lung Cancer: Heterogeneity in Treatment Recommendations for Stage III NSCLC According to Disease Burden and Oncogenic Driver Alterations. Clin Lung Cancer 2022 Feb 10. pii: S1525-7304(22)00015.
PMID: 35256282